Search results

Showing results for

Drs Samantha Vanderslott and Claas Kirchhelle introduce their typhoid history research and 'Alice in Typhoidland' public engagement project. This work delves into the history of typhoid in Oxford and highlights why typhoid is still a major global health problem needing both water, sanitation, and hygiene (WASH) interventions alongside vaccines.

In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.

Reiné J. et al, (2026), Comput Biol Chem, 122

Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.

Hysa A. et al, (2026), PLoS Med, 23

Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial.

Thorn N. et al, (2026), Lancet Infect Dis

Predicting trajectories of illness using RNA velocity of whole blood.

Dunican C. et al, (2026), Nat Commun, 17

"Intranasal vaccination with recombinant human adenovirus encoding the trans-sialidase gene protects mice from lethal subcutaneous and oral Trypanosoma cruzi trypomastigote challenges".

Noronha IH. et al, (2026), J Infect Dis

Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.

Jones E. et al, (2026), J Immunol, 215

African-specific genetic loci determine iron status and risk of severe malaria and bacteremia in African children.

Muriuki JM. et al, (2026), Nat Commun

Securing the future of immunisation: ESCMID's vision.

Ramasamy MN. et al, (2026), Clin Microbiol Infect, 32, 516 - 518

Maternal views on RSV vaccination in the UK's second season.

O'Hagan S. et al, (2026), Lancet Infect Dis, 26, e209 - e211

The association between vaccine coverage and herd protection: exploratory analyses of a cluster-randomised trial of Vi conjugate vaccine.

Zhang Y. et al, (2026), EClinicalMedicine, 94

Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.

Weiss SL. et al, (2026), Pediatr Crit Care Med, 27, 379 - 434

Correction: Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Walker J. et al, (2026), PLoS Negl Trop Dis, 20

Paediatric case of invasive group A streptococcal necrotising myositis: diagnostic challenges and lessons learned.

Yusuf S. et al, (2026), Lancet Infect Dis, 26, e259 - e267

Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.

Weiss SL. et al, (2026), Pediatr Crit Care Med, 27, 494 - 513

Immunisation of children and adolescents against COVID-19: immunogenicity and reactogenicity of heterologous and fractional dose schedules

Kelly E., (2026)

Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.

Weight CM. et al, (2026), J Infect Dis

Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.

Turan G. et al, (2026), Vaccines (Basel), 14

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Bijukchhe SM. et al, (2026), Lancet Infect Dis

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.

Cheliotis KS. et al, (2026), Vaccine, 75

13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults.

Tembo G. et al, (2026), Vaccine, 75

Search results

Showing results for

In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine.

Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.

Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial.

Predicting trajectories of illness using RNA velocity of whole blood.

"Intranasal vaccination with recombinant human adenovirus encoding the trans-sialidase gene protects mice from lethal subcutaneous and oral Trypanosoma cruzi trypomastigote challenges".

Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infection.

African-specific genetic loci determine iron status and risk of severe malaria and bacteremia in African children.

Securing the future of immunisation: ESCMID's vision.

Maternal views on RSV vaccination in the UK's second season.

The association between vaccine coverage and herd protection: exploratory analyses of a cluster-randomised trial of Vi conjugate vaccine.

Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.

Correction: Leveraging paired serology to estimate the incidence of typhoidal Salmonella infection in the STRATAA study.

Paediatric case of invasive group A streptococcal necrotising myositis: diagnostic challenges and lessons learned.

Executive Summary: Surviving Sepsis Campaign International Guidelines for the Management of Sepsis and Septic Shock in Children 2026.

Immunisation of children and adolescents against COVID-19: immunogenicity and reactogenicity of heterologous and fractional dose schedules

Disease-Attenuated Pneumococcal Biosynthesis Gene Mutants Invade the Mucosal Epithelium and Induce Innate Immunity.

Recent Advances, Bottlenecks, and Future Directions in Plasmodium falciparum Vaccine Development.

Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials.

Machine learning-driven identification of serotype-independent pneumococcal vaccine candidates using samples from human infection challenge studies.

13-valent pneumococcal conjugate vaccine-induced B cells produce serotype 6B but not serotype 3 capsule-specific IgG antibodies in young Malawian adults.

Similar stories

Statement on vaccine efforts relating to the Bundibugyo Ebolavirus outbreak in the DRC

The UK’s childhood vaccination schedule just changed. Here’s why that’s actually reassuring

Ambitious research aims to develop multivalent vaccines to protect against multiple deadly filoviruses

20 Years of Collaboration between OVG and Paediatric Research Unit, PAHS, Nepal

World's first Phase II Nipah virus vaccine trial launch

First Volunteer Receives Lassa Fever Vaccine in Cutting-edge Oxford Trial

Cookies on this website

Search results

Showing results for

Similar stories